Seres Therapeutics
MCRB
MCRB
69 hedge funds and large institutions have $1.03B invested in Seres Therapeutics in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
86% more call options, than puts
Call options by funds: $4M | Put options by funds: $2.15M
15% more funds holding
Funds holding: 60 → 69 (+9)
Holders
69
Holding in Top 10
2
Calls
$4M
Puts
$2.15M
Top Buyers
| 1 | +$16M | |
| 2 | +$13.3M | |
| 3 | +$6.31M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$4.72M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$4.32M |
Top Sellers
| 1 | -$7.31M | |
| 2 | -$5.33M | |
| 3 | -$3.61M | |
| 4 |
O
OrbiMed
New York
|
-$2.81M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.9M |